Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-10

FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for EPIVIR (lamivudine) filed by ViiV Healthcare Company, resulting in label/indication changes through the supplemental…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)

Snippet

SUPPL AP for EPIVIR (LAMIVUDINE)